Are fibrinogen levels elevated during pregnancy and the postpartum period, and should fibrinogen be measured when disseminated intravascular coagulation is suspected after postpartum hemorrhage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fibrinogen Monitoring in Suspected DIC After Postpartum Hemorrhage

Yes, fibrinogen levels should absolutely be checked when DIC is suspected after postpartum hemorrhage, as fibrinogen is a critical diagnostic marker and low levels (<1.5-2.0 g/L) predict severe coagulopathy requiring immediate intervention.

Why Fibrinogen Levels Are Elevated in Normal Pregnancy

During uncomplicated pregnancy, fibrinogen levels progressively increase throughout gestation as part of the physiologic hypercoagulable state:

  • Non-pregnant baseline: ~3.0 g/L
  • First trimester: ~3.3 g/L
  • Second trimester: ~4.0 g/L
  • Third trimester: ~4.4 g/L
  • At delivery: ~4.3 g/L 1, 2

This elevation protects against bleeding at delivery. However, this physiologic increase makes pregnancy-specific thresholds essential for diagnosing coagulopathy 3.

Critical Role of Fibrinogen in Obstetric DIC

When DIC Develops After PPH

In obstetric DIC, fibrinogen is rapidly consumed through:

  • Activation of the coagulation cascade
  • Consumption of clotting factors
  • Secondary fibrinolysis 4, 5

Key diagnostic finding: Unlike the expected elevation in pregnancy, fibrinogen levels drop precipitously in DIC, often falling below 1.5-2.0 g/L 6, 7.

Specific Diagnostic Thresholds

Fibrinogen ≤1.5 g/L in the setting of PPH indicates high risk for:

  • Maternal death
  • Massive transfusion requirement (≥10 units RBCs)
  • Need for invasive intervention (uterine artery embolization or hysterectomy) 6

Fibrinogen ≤2.0 g/L has been associated with:

  • Increased blood product transfusion
  • Worse maternal outcomes 3, 6

Diagnostic Approach to Suspected DIC After PPH

Essential Laboratory Tests

When DIC is suspected after PPH, obtain:

  1. Fibrinogen level (most critical single marker)
  2. Platelet count
  3. Prothrombin time (PT)
  4. D-dimer (elevated due to secondary fibrinolysis)
  5. Activated partial thromboplastin time (aPTT)

8, 4, 5

Apply Pregnancy-Modified DIC Scoring

The 2024 revised Japanese obstetric DIC score is specifically designed for pregnancy and includes:

  • Fibrinogen concentration (weighted heavily)
  • Platelet count
  • PT prolongation
  • Fibrin-related markers (D-dimer)

Score ≥8 points indicates overt DIC requiring immediate intervention 6, 7, 5

Critical Pitfall to Avoid

Do not use non-pregnant reference ranges for fibrinogen. A fibrinogen of 2.0 g/L might be "normal" outside pregnancy but represents significant consumption coagulopathy in a postpartum patient who should have levels >4.0 g/L 3, 2.

Special Consideration: Placental Abruption

In placental abruption specifically, fibrinogen levels may drop during the third trimester (to ~3.9 g/L) even before delivery, making this population particularly high-risk for DIC 2.

Management Implications

Once fibrinogen is measured and found to be low:

  • Target fibrinogen ≥1.5 g/L for hemostasis 9
  • Consider fibrinogen concentrate or cryoprecipitate replacement
  • Add tranexamic acid (TXA) to reduce fibrinolysis 9
  • Prepare for massive transfusion protocol if fibrinogen <1.5 g/L 6

Monitoring Frequency

In active PPH with suspected DIC:

  • Check fibrinogen every 12-24 hours during acute management 9
  • Continue monitoring for 3 days post-vaginal delivery or 5 days post-cesarean section 9

Bottom Line

Fibrinogen measurement is not optional when DIC is suspected after PPH—it is the single most important coagulation parameter for diagnosis, risk stratification, and guiding replacement therapy. The dramatic fall from pregnancy's elevated baseline (>4 g/L) to levels <2 g/L signals life-threatening coagulopathy requiring immediate aggressive intervention 3, 6, 7.

References

Research

Fibrinogen and its fraction during pregnancy and puerperium.

Biological research in pregnancy and perinatology, 1984

Research

Changes in Fibrinogen and D-Dimer During Complicated and Uncomplicated Pregnancy.

International journal of laboratory hematology, 2025

Research

The role of fibrinogen in postpartum hemorrhage.

Best practice & research. Clinical anaesthesiology, 2022

Research

Is blood transfusion necessary in all patients with disseminated intravascular coagulation associated postpartum hemorrhage?

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.